Comprehensive genomic profiling

One biomarker can make a difference.

Every year, promising cancer therapies are developed and approved, offering the potential for improved clinical outcomes for patients with qualifying cancer types. Comprehensive genomic profiling (CGP) can detect actionable variants to maximize the ability to match patients with appropriate molecular treatment regimens.

Accelerate precision medicine, maximize identification of molecularly matched therapies.

Download the eBook now to learn more. 

Download the CGP eBook now to learn more

Please keep me informed on products and services from Illumina

By submitting this form, you agree to have your contact information passed along for the purpose of following up on your interests and in order receive communications regarding Illumina products, services, and events. The data sent will be processed in Canada and provided to Illumina who will assume responsibility for processing and Opt-out and Information Removal. For more information, please read our Terms of Use, Privacy, Opt-out & Information Removal.